Viome is a precision nutrition company that aims to prevent and reverse chronic diseases by digitizing and decoding each individual's biology, starting with the gut microbiome. They analyze RNA (gene expression) to gain a comprehensive understanding of an individual's body and provide personalized food recommendations and made-to-order supplements. Viome is focused on advancing precision diagnostics and therapeutics for chronic diseases, cancer, and aging.

Viome | A Viome Life Sciences, Inc. Company.

We provide the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need.

By joining Viome, you are joining a revolutionary movement. A movement that – for the first time in human history – will make becoming ill a matter of choice, and not simply bad luck.

Scientists have worked for over a decade to develop this technology that offers unprecedented visibility into your body. With this, we can create a unique profile of the biochemistry and ecosystem inside of you, and make personalized, actionable, and adaptive recommendations for your health.

Our at-home tests are not just one-time tests, but your true health companion, enabling you to monitor your health over time. Your results and recommendations adapt to your changing ecosystem so you are always aware and taking action towards maximizing your vitality and lifespan.

The Viome team is made up of scientists, engineers, researchers and entrepreneurs who are passionate about radically improving the wellness of our customers.

Bold Capital Partners

Khosla Ventures

Physician Partners

Hambrecht Healthcare Growth Venture Fund

Nomad Capital Partners

Marc Benioff

Matthew Harris

WestRiver Group

Ezaki Glico

Ocgrow Ventures

Viome

🎉 Wrapping up National Dental Hygiene Month and National Orthodontic Health Month with a Milestone! 🎉

As October concludes, it's not just the commitment to dental and orthodontic health that we celebrate but also the advancements in science that have the power to transform lives. Today, we're especially proud to highlight Viome's CancerDetect Test for Oral & Throat.

🔍 Here's why this is a game-changer:

✅ Breakthrough Technology: The FDA granted the breakthrough device designation to the technology behind CancerDetect. The technology behind CancerDetect is the same cutting-edge technology that powers Viome's Intelligence wellness tests. The breakthrough designation helps the FDA identify new technology to focus on in order to expedite access to novel devices that will save lives and treat debilitating diseases. The Breakthrough Program's purpose is clear: to ensure patients have swifter access to life-changing medical devices by hastening their journey from development to patient use.

✅ First of Its Kind Early Detection: CancerDetect is the first-ever test to identify biomarkers associated with oral and throat cancers with unmatched accuracy, including early stages, with a specificity of 95% and a sensitivity of 90%.

✅ Addressing a Critical Gap: Designed primarily for individuals at a higher risk of these cancers, CancerDetect addresses an urgent need for innovative solutions. Early detection is pivotal; when these cancers are diagnosed in the early stages, the 5-year survival rate can soar to 84%, a stark contrast to the sobering statistics of less than 50% when detected late.

In the spirit of National Dental Hygiene & Orthodontic Health Month, we not only emphasize the importance of regular oral care but also champion early detection and timely intervention. CancerDetect™ is redefining the future of oral and throat cancer diagnosis and treatment.

Learn more: https://www.viomepro.com/

To everyone involved in its development and to those who will benefit from it - here's to a brighter, healthier tomorrow! 🌟 #NationalDentalHygieneMonth #NationalOrthodonticHealthMonth #CancerDetect #OralMicrobiome #OralHealth #EarlyDetectionMatters

Viome is committed to our mission: envisioning a world where chronic illness becomes a matter of choice, not fate. We recognize the enormity of this challenge and its complexities, yet we are confident that by bringing the best minds together, we can significantly reduce the impact of chronic diseases. We're privileged to have the backing of eminent scientists and physicians who champion Viome's effort to push microbiome science and technology forward.

The new Oral Health Pro with CancerDetect from Viome can help #dental professionals detect markers for oral cancers and other oral and systemic conditions. https://lnkd.in/g7KCkY8N

The new offering relies on Viome's proprietary RNA sequencing technology and AI to identify early biomarkers associated with oral and throat cancers

COM:VIOME

Viome

Analysis Not Available